Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects.
The central administration of the fatty acid synthase (FAS) inhibitor, C75, rapidly suppresses the expression of orexigenic neuropeptides [neuropeptide Y (NPY) and agouti-related protein (AgRP)] and activates expression of anorexigenic neuropeptides [proopiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART)] in the hypothalamus. The combined actions of these changes inhibit food intake and decrease body weight. Intracerebroventricular injection of C75 appears to rapidly inhibit the secretion of ghrelin by hypothalamic explants ex vivo and by the stomach in vivo. Ghrelin administered intracerebroventricularly reverses the anorexic effect of C75, suggesting that C75 acts upstream of ghrelin. Because ghrelin-producing neurons are known to form synapses onto NPY/AgRP neurons, we suggest that the reversal of C75-induced anorexia by ghrelin may be mediated by NPY/AgRP neurons. This hypothesis is supported by the finding that ghrelin reverses the C75-induced inactivation (assessed by c-Fos expression) of neurons in the arcuate nucleus that express NPY (assessed by immunohistochemical costaining). These effects closely correlate with appropriate changes downstream in the expression of the hypothalamic neuropeptides that regulate feeding behavior, i.e., down-regulation of the expression of NPY and AgRP and up-regulation of the expression of proopiomelanocortin/alpha-melanocyte-stimulating hormone, provoked by C75 and reversed by ghrelin. We propose a model in which ghrelin secretion plays an intermediary role between malonyl-CoA, the substrate of fatty acid synthase, and the neural circuitry regulating energy homeostasis.
Hu
Zhiyuan
Z
Department of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Cha
Seung Hun
SH
van Haasteren
Goedelle
G
Wang
Jing
J
Lane
M Daniel
MD
D015107:4-Butyrolactone / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000818:Animals; D064429:Fatty Acid Synthases / Q000037:antagonists & inhibitors*; D054439:Ghrelin; D007031:Hypothalamus / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D009479:Neuropeptides / Q000096:biosynthesis / Q000235:genetics; D036361:Peptide Hormones / Q000097:blood / Q000378:metabolism*; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism; D013270:Stomach / Q000187:drug effects*
C406734:4-methylene-2-octyl-5-oxofuran-3-carboxylic acid; D054439:Ghrelin; D009479:Neuropeptides; D036361:Peptide Hormones; D016760:Proto-Oncogene Proteins c-fos; D012333:RNA, Messenger; D064429:Fatty Acid Synthases; D015107:4-Butyrolactone
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1921-5
11854492
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):66-71
11756683
Isr Med Assoc J. 2002 Aug;4(8):607-13
12183865
Gastroenterology. 2002 Oct;123(4):1120-8
12360474
Biochem Soc Trans. 2002 Nov;30(Pt 6):1064-70
12440973
Annu Rev Med. 2003;54:453-71
12414915
Neuron. 2003 Feb 20;37(4):649-61
12597862
Diabetes. 2003 Apr;52(4):948-56
12663466
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5628-33
12724522
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12624-9
14532332
Eur J Pharmacol. 2003 Nov 7;480(1-3):3-11
14623345
J Biol Chem. 2004 Jan 30;279(5):3817-27
14615481
Recent Prog Horm Res. 2004;59:395-408
14749511
Nature. 2004 Apr 1;428(6982):569-74
15058305
Biochem Biophys Res Commun. 2004 Apr 30;317(2):301-8
15063757
Mol Cell Endocrinol. 2004 Feb 12;214(1-2):81-95
15062547
J Physiol Pharmacol. 2004 Mar;55(1 Pt 2):137-54
15082874
J Biol Chem. 2004 May 7;279(19):19970-6
15028725
Endocrinology. 2004 Jun;145(6):2607-12
14962995
Endocrinology. 2004 Jun;145(6):2604-6
15140838
Adv Enzymol Relat Areas Mol Biol. 1971;35:321-442
4150153
Biochemistry. 1989 May 30;28(11):4523-30
2669958
Prog Lipid Res. 1989;28(2):117-46
2575259
J Appl Physiol (1985). 1997 Jan;82(1):219-25
9029219
Nature. 1999 Dec 9;402(6762):656-60
10604470
Nature. 2000 Apr 6;404(6778):661-71
10766253
Science. 2000 Jun 30;288(5475):2379-81
10875926
Biochem Biophys Res Commun. 2000 Oct 5;276(3):905-8
11027567
Nature. 2000 Oct 19;407(6806):908-13
11057670
Endocrinology. 2000 Nov;141(11):4255-61
11089560
Nature. 2001 Jan 11;409(6817):194-8
11196643
Biochem Biophys Res Commun. 2000 Dec 29;279(3):909-13
11162448
Biochem Biophys Res Commun. 2001 Jan 26;280(3):904-7
11162609
J Endocrinol. 2002 Aug;174(2):283-8
12176667